TickerFacts.

Nuvectis Pharma, Inc. (NVCT): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

25.68M
As of 2025-12-31
26.69M
As of 2026-06-30
+19.1%
3-year compound annual growth
2021-12-31: 4.51M2022-12-31: 15.19M2023-12-31: 17.42M2024-12-31: 19.50M2025-12-31: 25.68M25.68M
2021-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3125.68M+31.7%2026-02-11, Balance as of period end
2024-12-3119.50M+11.9%2026-02-11, Balance as of period end
2023-12-3117.42M+14.7%2025-02-25, Balance as of period end
2022-12-3115.19Mn/c2024-03-05, Balance as of period end
2021-12-314.51Mn/a2023-03-08, Balance as of period end